Mapping the trajectory from pre-COPD to COPD: predictive value of symptoms, imaging, and physiologic abnormalities

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (K23HL151751)
  • National Institutes of Health (K24HL138188)
  • Solovy Award for Advancement
  • Respiratory Health Association (NCT00608764)
  • National Heart, Lung, and Blood Institute (U01HL089897)
  • National Heart, Lung, and Blood Institute (U01HL089856)
  • COPD Foundation
  • Industry Advisory Committee
  • AstraZeneca
  • Bayer Pharmaceuticals
  • Boehringer-Ingelheim
  • GlaxoSmithKline

This publication has 20 references indexed in Scilit: